Your browser doesn't support javascript.
loading
The pharmaco-invasive strategy with half-dose recombinant human prourokinase in treating patients with acute ST-segment elevation myocardial infarction (STEMI): The 2-year follow-up of bleeding events.
Dou, Jie; Yang, Hui-Hui; Wang, Xue-Yan; Luo, Dong-Lei.
Affiliation
  • Dou J; Chengde Medical University, Chengde, China.
  • Yang HH; Chengde Medical University, Chengde, China.
  • Wang XY; Chengde Central Hospital, Second Clinical College of Chengde Medical University, Chengde, China. Electronic address: 617568935@qq.com.
  • Luo DL; Chengde Central Hospital, Second Clinical College of Chengde Medical University, Chengde, China. Electronic address: dongleiluocn@aliyun.com.
Asian J Surg ; 47(6): 2950-2951, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38418322
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Urokinase-Type Plasminogen Activator / ST Elevation Myocardial Infarction / Hemorrhage Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Asian J Surg Year: 2024 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Urokinase-Type Plasminogen Activator / ST Elevation Myocardial Infarction / Hemorrhage Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Asian J Surg Year: 2024 Document type: Article Affiliation country: